Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
ilaprazole IP (10 mg EC) + Domperidone IP (30 mg SR) Capsule
Therapeutic Category
Gastroenterology, Antacid
Dosage Form
Capsule
Packaging Type
Alu Alu
Packaging
10*10
Price
₹229/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ilaprime DSR Capsule is a dual-action gastroprokinetic and acid-suppressing formulation designed to manage acid-related gastrointestinal disorders. Ilaprazole is a potent, long-acting proton pump inhibitor (PPI) that irreversibly inhibits the H+/K+ ATPase enzyme in gastric parietal cells, effectively reducing gastric acid secretion and promoting ulcer healing. Its enteric-coated form ensures stability and targeted release in the intestine. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastric motility and accelerates gastric emptying, thereby reducing symptoms of nausea, vomiting, bloating, and reflux. The sustained-release formulation of Domperidone provides prolonged therapeutic action with once-daily dosing. This combination is particularly beneficial in treating conditions where both acid suppression and improved motility are required, offering comprehensive relief in gastroesophageal reflux disease (GERD) and dyspepsia.
Common side effects include headache, abdominal discomfort, diarrhea, dry mouth, dizziness, and mild nausea. Long-term PPI use may increase the risk of vitamin B12 deficiency, hypomagnesemia, and, rarely, bone fractures. Domperidone may cause mild QT prolongation in sensitive individuals; hence, caution is advised in patients with cardiac arrhythmias or electrolyte disturbances. Allergic reactions, although rare, can manifest as rash or swelling.
Ilaprime DSR Capsule is indicated for the management of gastroesophageal reflux disease (GERD), acid peptic disorders, erosive esophagitis, dyspepsia, and reflux-related nausea or vomiting. It may also be used as part of combination therapy for peptic ulcer disease and functional dyspepsia under medical supervision.
Ilaprime DSR Capsule should be taken before meals as directed by the physician. It is contraindicated in patients with severe hepatic impairment, gastrointestinal bleeding, perforation, obstruction, or known hypersensitivity to PPIs or Domperidone. Caution is advised in patients with cardiac conditions or prolonged QT interval. Prolonged use of PPIs should be avoided unless prescribed, and dose tapering may be required to prevent rebound acid hypersecretion. This product is not recommended during pregnancy and lactation unless the potential benefits outweigh the risks. Avoid concomitant use with potent CYP3A4 inhibitors or medications that prolong QT interval without medical supervision.
Store Ilaprime DSR Capsule in a cool, dry place below 30°C, away from direct sunlight and moisture. Keep the capsules in their original blister packaging and out of reach of children. Do not use beyond the expiry date printed on the pack.
Composition : Cinitapride (3mg) + Pantoprazole (40mg)
Composition : Domperidone (30mg) + Pantoprazole (40mg)
Composition : Pantoprazole (E.C.) I.P. 40mg (E.C.) + Domperidone (I.R.) I.P. 10mg + Domperidone (S.R.) I.P. 20mg Capsules
Composition : Pantoprazole (40mg) + Itopride (150mg)
Composition : Levosulpiride (75mg) + Pantoprazole (40mg)
Composition : Pantoprazole (40mg) Injection
Composition : Pantoprazole (20mg)
Composition : Domperidone (10mg) + Pantoprazole (40mg)
Composition : Pantoprazole (80mg) Dual Release Gastro-Resistant
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination capsule is used for acid reflux, GERD, gastritis, nausea, and indigestion, making it a strong gastro prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in acidity, reflux disease, bloating, nausea, and gastric discomfort. It is commonly prescribed by gastroenterologists and general physicians for effective acid control with antiemetic support.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Ilaprazole + Domperidone DSR Capsules with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high prescription volume in gastro clinics, long-term chronic patient demand, and strong outpatient pharmacy sales when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this gastro combination formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.